First Page | Document Content | |
---|---|---|
Eli Lilly and Company Peptide hormones Recombinant proteins Diabetes Insulin analog Insulin glulisine Tmax Pharmacokinetics Insulin Pharmaceutical sciences Pharmacology Medicine | OFFICE OF CLINICAL PHARMACOLOGY REVIEW NDA: [removed]S-015 Submission Date:Add to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 714,09 KBShare Document on Facebook |